BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 8274876)

  • 1. Inhibition of 1,25(OH)2D production by hypercalcemia in osteitis fibrosa cystica: influence on parathyroid hormone secretion and hungry bone disease.
    Brossard JH; Garon J; Lepage R; Gascon-Barré M; D'Amour P
    Bone Miner; 1993 Oct; 23(1):15-26. PubMed ID: 8274876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D metabolism during recovery from severe osteitis fibrosa cystica of primary hyperparathyroidism.
    Gonzalez-Villapando C; Porath A; Berelowitz M; Marshall L; Favus MJ
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1180-3. PubMed ID: 6893459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marked direct suppression of primary hyperparathyroidism with osteitis fibrosa cystica by intravenous administration of 1,25-dihydroxycholecalciferol.
    Patron P; Gardin JP; Borensztein P; Prigent A; Paillard M
    Miner Electrolyte Metab; 1989; 15(6):321-5. PubMed ID: 2615719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery.
    Räkel A; Brossard JH; Patenaude JV; Albert C; Nassif E; Cantor T; Rousseau L; D'Amour P
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):721-7. PubMed ID: 15943835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Osteitis fibrosa cystica von Recklinghausen].
    Røkke O; Due J; Dale K
    Tidsskr Nor Laegeforen; 1990 Mar; 110(8):960-1. PubMed ID: 2321226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of parathyroid adenoma resection on bone density in primary hyperparathyroidism and osteitis fibrosa cystica.
    Knee TS; Drake AJ; Turton D; Shakir KM
    Orthopedics; 2001 Oct; 24(10):1000-2. PubMed ID: 11688767
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous 1,25(OH)2D therapy increases the intact parathyroid hormone secretion set point in hemodialyzed patients.
    Brossard JH; Roy L; Lepage R; Gascon-Barré M; D'Amour P
    Miner Electrolyte Metab; 1997; 23(1):25-32. PubMed ID: 9058366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D status in primary hyperparathyroidism in India.
    Harinarayan CV; Gupta N; Kochupillai N
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):351-8. PubMed ID: 7586606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous healing of osteitis fibrosa cystica in primary hyperparathyroidism.
    Gibbs CJ; Millar JG; Smith J
    Postgrad Med J; 1996 Dec; 72(854):754-7. PubMed ID: 9015472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A patient with a history of breast cancer and multiple bone lesions: a case report.
    Schnyder MA; Stolzmann P; Huber GF; Schmid C
    J Med Case Rep; 2017 May; 11(1):127. PubMed ID: 28476174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretion of parathyroid hormone in primary hyperparathyroidism.
    O'Riordan JL; Watson L; Woodhead JS
    Clin Endocrinol (Oxf); 1972 Apr; 1(2):149-55. PubMed ID: 4664380
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary hyperparathyroidism with low serum 1,25-dihydroxyvitamin D levels.
    Wortsman J; Haddad JG; Posillico JT; Brown EM
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1305-8. PubMed ID: 3754562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suspected Malignant Lesion of the Hip Resolves after Parathyroidectomy: Osteitis Fibrosa Cystica (or Brown Tumor): A Case Report.
    Alvine O; Alvine G
    S D Med; 2018 Apr; 71(4):176-178. PubMed ID: 29996036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal osteodystrophy in dialysis patients: diagnosis and treatment.
    Fournier A; Oprisiu R; Hottelart C; Yverneau PH; Ghazali A; Atik A; Hedri H; Said S; Sechet A; Rasolombololona M; Abighanem O; Sarraj A; El Esper N; Moriniere P; Boudailliez B; Westeel PF; Achard JM; Pruna A
    Artif Organs; 1998 Jul; 22(7):530-57. PubMed ID: 9684690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure.
    Andress DL; Norris KC; Coburn JW; Slatopolsky EA; Sherrard DJ
    N Engl J Med; 1989 Aug; 321(5):274-9. PubMed ID: 2631697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brown tumor due to primary hyperparathyroidism in a familial case: a case report.
    Diao Z; Zhang J; Zhao J; Sun W; Pu Z
    BMC Endocr Disord; 2023 Oct; 23(1):214. PubMed ID: 37807045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological activity of endogenous and exogenous calcitonin in patients with osteitis fibrosa and chronic renal failure.
    Cundy T; Heynen G; Paton S; Ledingham JG; Russell RG; Oliver DO; Kanis JA
    Proc Eur Dial Transplant Assoc; 1978; 15():524-31. PubMed ID: 740683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum multichannel autoanalyzers in the detection of hypercalcemia and hyperparathyroidism.
    Mays ET; Weakley SD
    Surg Gynecol Obstet; 1971 Oct; 133(4):603-8. PubMed ID: 5096308
    [No Abstract]   [Full Text] [Related]  

  • 19. Healing of osteitis fibrosa cystica after partial parathyroidectomy despite persistent parathyroid hyperfunction: a case report.
    Mautalen CA; Gonzalez D; Casco C; Fromm GA
    Metab Bone Dis Relat Res; 1982; 4(3):187-91. PubMed ID: 7154936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathologic fracture of the femur due to primary hyperparathyroidism].
    Pérez JA; López B; Valdivia P; Norambuena L
    Rev Med Chil; 1989 Sep; 117(9):1018-22. PubMed ID: 2519466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.